Claudio Zamperini

1.2k total citations
39 papers, 1.0k citations indexed

About

Claudio Zamperini is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Claudio Zamperini has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Organic Chemistry and 13 papers in Infectious Diseases. Recurrent topics in Claudio Zamperini's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Neuroblastoma Research and Treatments (5 papers). Claudio Zamperini is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Neuroblastoma Research and Treatments (5 papers). Claudio Zamperini collaborates with scholars based in Italy, United States and Belgium. Claudio Zamperini's co-authors include Maurizio Botta, Elena Dreassi, Giovanni Maga, Silvia Schenone, Cristina Tintori, Emmanuele Crespan, Francesca Musumeci, Marco Radi, Annalaura Brai and Adriano Angelucci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Claudio Zamperini

38 papers receiving 989 citations

Peers

Countries citing papers authored by Claudio Zamperini

Since Specialization

Citations

This map shows the geographic impact of Claudio Zamperini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Zamperini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Zamperini more than expected).

Fields of papers citing papers by Claudio Zamperini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Zamperini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Zamperini. The network helps show where Claudio Zamperini may publish in the future.

Co-authorship network of co-authors of Claudio Zamperini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Zamperini. A scholar is included among the top collaborators of Claudio Zamperini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Zamperini. Claudio Zamperini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma 2023 ·Pharmaceutical Chemistry Journal ·(unknown), (unknown), Claudio Zamperini, (unknown), Emmanuele Crespan, (unknown), (unknown), Simona Saponara, Fabio Fusi, Giovanni Maga, Adriano Angelucci, Eugenio Gaudio, (unknown), Silvia Schenone, Lorenzo Botta, Elena Dreassi, Maurizio Botta	0
2	Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells ex-vivo 2023 ·Microbiology Spectrum ·(unknown), (unknown), S. F. Paul Man, (unknown), (unknown), Claudio Zamperini, Alessia Tarditi, Neeltje A. Kootstra, Teunis B. H. Geijtenbeek	4
3	The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 2022 ·Biomedicines ·(unknown), Fabio Pastorino, Chiara Brignole, Arianna Mancini, (unknown), (unknown), Claudio Zamperini, (unknown), Anna Lucia Fallacara, (unknown), (unknown), Massimo Valoti, Silvia Schenone, Adriano Angelucci, Mirco Ponzoni, Elena Dreassi, Maurizio Botta	8
4	Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 2021 ·European Journal of Medicinal Chemistry ·(unknown), Lucia D’Antona, (unknown), Annalaura Brai, Arianna Mancini, Claudio Zamperini, (unknown), (unknown), Anna Lucia Fallacara, (unknown), (unknown), Silvia Schenone, Nicola Perrotti, Elena Dreassi, Maurizio Botta	10
5	A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 2019 ·Cancers ·Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, (unknown), Arianna Mancini, (unknown), (unknown), (unknown), Francesca Bugli, Maurizio Sanguinetti, Riccardo Torelli, Maurizio Martini, Laura Maccari, Massimo Valoti, Elena Dreassi, Maurizio Botta, Milica Pešić, Silvia Schenone	39
6	In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains 2019 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), (unknown), Ilaria D’Agostino, (unknown), (unknown), Claudio Zamperini, Elena Dreassi, Laura Maccari, Riccardo Torelli, Cécilia Martini, (unknown), Jacques F. Meis, Nitesh Khandelwal, Rajendra Prasad, Maurizio Sanguinetti, Francesca Bugli, Maurizio Botta	17
7	Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular Carcinoma 2018 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Claudio Zamperini, (unknown), Elena Dreassi, M Chiariello, Adriano Angelucci, Silvia Schenone, Maurizio Botta, Arianna Mancini	4
8	Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Anna Lucia Fallacara, (unknown), Claudio Zamperini, (unknown), Francesca Musumeci, Silvia Schenone, Adriano Angelucci, Alessandro Colapietro, Emmanuele Crespan, (unknown), Giovanni Maga, Maurizio Botta	22
9	Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides 2018 ·PLoS ONE ·Cristina Tintori, (unknown), Elisa Rita Ceresola, Roberto Ferrarese, Claudio Zamperini, Annalaura Brai, Giulio Poli, Elena Dreassi, Valeria Cagno, David Lembo, Filippo Canducci, Maurizio Botta	28
10	Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents 2017 ·Scientific Reports ·Claudio Zamperini, (unknown), Davide Deodato, Chris Pasero, Ilaria D’Agostino, (unknown), Filomena De Luca, Elena Dreassi, Jean‐Denis Docquier, Maurizio Botta	29
11	Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 2017 ·Journal of Medicinal Chemistry ·Gianluca Vignaroli, (unknown), Claudio Zamperini, (unknown), (unknown), (unknown), Anna Lucia Fallacara, (unknown), (unknown), David Colecchia, A. Mancini, Claudio Festuccia, Elena Dreassi, Massimo Valoti, Francesca Musumeci, M Chiariello, Adriano Angelucci, Maurizio Botta, Silvia Schenone	31
12	Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line 2017 ·Bioorganic & Medicinal Chemistry Letters ·Anna Lucia Fallacara, Arianna Mancini, Claudio Zamperini, Elena Dreassi, (unknown), M Chiariello, Gianni Pozzi, Francesco Santoro, (unknown), Silvia Schenone	23
13	Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells 2016 ·Molecular Cancer Therapeutics ·(unknown), Gianluca Vignaroli, Claudio Zamperini, (unknown), Claudio Festuccia, Ernesto Di Cesare, Giovanni Luca Gravina, Claudia De Mattei, Flora Vitale, Silvia Schenone, Maurizio Botta, Adriano Angelucci	30
14	In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51 2016 ·European Journal of Medicinal Chemistry ·Daniela De Vita, Francesca Moraca, Claudio Zamperini, Fabiana Pandolfi, Roberto Di Santo, An Matheeussen, Louis Maes, Silvano Tortorella, Luigi Scipione	18
15	Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery 2016 ·Scientific Reports ·Gianluca Vignaroli, (unknown), Claudio Zamperini, (unknown), (unknown), (unknown), David Colecchia, Elena Dreassi, Massimo Valoti, Silvia Schenone, M Chiariello, Maurizio Botta	23
16	New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2 2014 ·European Journal of Medicinal Chemistry ·Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, Valeria Famiglini, Antonio Coluccia, Anna Ruggieri, Simona Anticoli, Jin‐Ching Lee, Amartya Basu, Özge Çevik, Lucia Nencioni, Anna Teresa Palamara, Claudio Zamperini, Maurizio Botta, Johan Neyts, Pieter Leyssen, Neerja Kaushik‐Basu, Romano Silvestri	22
17	CYP-dependent Metabolism of Antitumor Pyrazolo[3,4-d]pyrimidine Derivatives Is Characterized by an Oxidative Dechlorination Reaction 2014 ·Drug Metabolism and Pharmacokinetics ·Claudio Zamperini, Elena Dreassi, Gianluca Vignaroli, Marco Radi, Stefania Dragoni, Silvia Schenone, Francesca Musumeci, Massimo Valoti, Riccarda Antiochia, Maurizio Botta	6
18	Synthesis of linear and cyclic guazatine derivatives endowed with antibacterial activity 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Filomena De Luca, Davide Deodato, (unknown), (unknown), Claudio Zamperini, Elena Dreassi, Gian María Rossolini, Jean‐Denis Docquier, Maurizio Botta	15
19	A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation 2012 ·Bioorganic & Medicinal Chemistry Letters ·Marco Radi, Lasse Evensen, Elena Dreassi, Claudio Zamperini, (unknown), Federico Falchi, Francesca Musumeci, Silvia Schenone, James B. Lorens, Maurizio Botta	19
20	Synthesis, Biological Activity, and ADME Properties of Novel S‐DABOs/N‐DABOs as HIV Reverse Transcriptase Inhibitors 2012 ·ChemMedChem ·Marco Radi, (unknown), (unknown), Daniele Castagnolo, Silvia Schenone, (unknown), Claudio Zamperini, Elena Dreassi, Giovanni Maga, Alberta Samuele, (unknown), Bonaventura Clotet, José A. Esté, Maurizio Botta	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact